ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

List of FY97 SPORE Grantees and Their Awards

December 12, 1997

Five NCAB members complete terms.

February 20, 2004

Drug Development Effort Criticized

April 18, 1975

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998